Throughout history, innovations have transformed industries and turned impossibilities into realities. Technologies are key enablers of these transformations. In Mind to Market: Commercializing University Technologies (Part 1), we learned that technologies and inventions, when successfully translated into marketable products and applications, can have significant impact on the economy and create money-making opportunities. But with opportunities [...]
Back in April, we met a patent attorney through Greg George, who suggested we do a post on intellectual property (IP). Law? IP? *yawn* Before you doze off, wait! This patent attorney happened to be McGarry Bair’s (@McGarryBair) Tom Williams (@RealGTom), who’s fun, witty, and enthusiastic – not your typical lawyer. In fact, McGarry Bair [...]
In Part 1 of the interview, Implications of IP for Angel Investors, patent attorney Tom Williams (@RealGTom) of McGarry Bair (@McGarryBair) provided a summary of various forms of intellectual property (IP) and explained how IP produces money-making opportunities. Here, he’ll talk about several common mistakes startups make, provide an overview on IP insurance, and point [...]
As an angel, you play with your own money and make bets on your dime. You take calculated risks and take precaution steps to reduce known risks. That’s how you protect your investments and improve the odds of success. Product risk is one of the investment risks inherit in angel investing. You want to reduce [...]
In Part 1, we talked about how angel groups are increasingly collaborating and co-investing with each other to increase investment size, reduce financial risk, and tap into the wisdom of the crowd. To give a vivid picture, we asked Paul G. Silva, managing partner of Angel Catalyst and group manager at River Valley Investors (RVI), [...]
What happens when an angel group comes across, or has in its portfolio, a high-potential company requiring an investment amount that’s too big for an individual group but too small for VCs? Most likely, it’ll engage in an angel group syndication, “a practice that allows groups to pool their funds to support larger investments” that [...]
What’s it like to back a life sciences company? What should investors expect before investing in the bio/health sectors? Who’s entitled to be called an “angel investor”? These are some of the questions Thealzel Lee will answer in this interview. Lee is the senior partner of Rocket Builders, a management consulting firm that sponsors Vancouver [...]
In Part 1 of the interview, Rob Delman, managing director of Golden Seeds New York, told us the benefits of investing in women-led ventures, shared his lessons learned and pointed out a critical term in a term sheet that many might have overlooked. Today, Delman the “Golden Dude” talks more about due diligence, an area [...]
A month ago just before Christmas, Rob Delman of Golden Seeds (aka the “Golden Dude”) played Santa and dropped a gift packed with pitch preparation tips (for angels) down our chimney. We loved it and so did you. It’s a given – we’re very greedy when it comes to angel investing tips and insights. So [...]
What’s technology transfer? Broadly speaking, it’s the process of transferring technology, knowledge, or scientific findings from research labs to commercial sectors. Continuing last week’s conversation on tech-led economic development and research park startup companies, Brian Darmody talks about tech transfer models, the role startups play in facilitating tech transfer, favorite company success story and more. [...]
Venture Hype respects your privacy. We'll never sell or share your email, and you may unsubscribe anytime.
I was very impressed by the balance shown in a recent pair of postings to Venture Hype by a guest author. Many news writers don’t even try to iron out bias or preference and I saw a really good-faith, conscious effort here that made me a subscriber!
